Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, 1981 Tsujido-machi, Kamoda, Kawagoe, Saitama, 350-8550, Japan.
Surg Today. 2009;39(12):1032-9. doi: 10.1007/s00595-009-3994-9. Epub 2009 Dec 8.
We performed a prospective randomized study to assess the effectiveness of short-term intravenous antimicrobial prophylaxis in combination with preoperative oral antibiotics on a surgical site and methicillin-resistant Staphylococcus aureus (MRSA) infection in elective colon cancer surgery.
The patients were administered preoperative oral antibiotics, kanamycin and erythromycin, after mechanical cleansing, which began within 24 h of elective surgery for colon cancer. The patients were randomly assigned to receive the intravenous administration of cefmetazol or cefotiam on the day of surgery (group 1) or for 3 days (group 2). A total of 275 patients (136 for group 1 and 139 for group 2) were eligible for the study.
The incidence of a surgical site infection was 5.1% in group 1 and 6.5% in group 2 (P = 0.80). The incidence of MRSA infection was 2.2% in group 1 and 2.9% in group 2 (P > 0.99). A multivariate logistic regression analysis showed that the American Society of Anesthesiologists physical status score and the duration of surgery were independent significant factors affecting the surgical site infection and MRSA infection.
These findings suggest that short-term intravenous antimicrobial prophylaxis in combination with preoperative oral antibiotics may be successfully applied to colon cancer surgery that is generally performed in Japan.
我们进行了一项前瞻性随机研究,以评估在择期结肠癌手术中,短期静脉内抗菌预防与术前口服抗生素联合使用对手术部位和耐甲氧西林金黄色葡萄球菌(MRSA)感染的效果。
在机械清洗后,即择期结肠癌手术前 24 小时内,患者给予术前口服抗生素,即卡那霉素和红霉素。患者被随机分配在手术当天接受头孢美唑或头孢替安的静脉给药(第 1 组)或连续 3 天(第 2 组)。共有 275 例患者(第 1 组 136 例,第 2 组 139 例)符合研究条件。
第 1 组的手术部位感染发生率为 5.1%,第 2 组为 6.5%(P=0.80)。第 1 组的 MRSA 感染发生率为 2.2%,第 2 组为 2.9%(P>0.99)。多变量逻辑回归分析显示,美国麻醉医师协会身体状况评分和手术持续时间是影响手术部位感染和 MRSA 感染的独立显著因素。
这些发现表明,短期静脉内抗菌预防与术前口服抗生素联合使用可能成功应用于日本普遍进行的结肠癌手术。